Femto Technologies Inc. has achieved a significant milestone in its technological development after receiving a Notice of Allowance from the U.S. Patent and Trademark Office for its Sensera device design. The patent reinforces the company's position in the emerging femtech sector, highlighting its commitment to innovative wellness solutions powered by artificial intelligence.
The Sensera device, recently honored as a CES Innovation Awards® 2025 honoree in the AI category, represents a breakthrough in feminine wellness technology. Its proprietary Smart Release System (SRS) technology integrates machine learning and artificial intelligence to provide a personalized approach to women's health and wellness.
CEO Yftah Ben Yaackov emphasized the importance of this patent, noting that the recognition underscores the company's leadership in developing transformative technological solutions. The patent approval validates Femto's research and development efforts, which are centered on creating adaptive and intelligent wellness products.
The Sensera device aims to bridge gaps in feminine wellness by offering a holistic self-care experience that can dynamically respond to changing user needs. By leveraging advanced AI technologies, Femto Technologies is positioning itself at the forefront of personalized health innovation.
This patent represents more than a legal milestone; it signals the growing intersection of artificial intelligence, healthcare technology, and personalized wellness solutions. As the femtech sector continues to evolve, Femto Technologies' approach demonstrates the potential for technology to create more responsive and individualized health experiences.
